AU Patent

AU2015201409B2 — Compounds as modulators of a mutant CFTR protein and their use for treating diseases associated with CFTR protein malfunction

Assigned to Instytut Biochemii I Biofizyki of PAN · Expires 2016-11-03 · 10y expired

What this patent protects

H:\rbr\Interwoven\NRPortbl\DCC\RBR\75131991l.docx-3/03/2015 Abstract The present invention relates to novel protein modulators capable of altering function of the mutant CFTR protein and their use for treating diseases associated with CFTR protein malfunction. The invention provi…

USPTO Abstract

H:\rbr\Interwoven\NRPortbl\DCC\RBR\75131991l.docx-3/03/2015 Abstract The present invention relates to novel protein modulators capable of altering function of the mutant CFTR protein and their use for treating diseases associated with CFTR protein malfunction. The invention provides compositions, pharmaceutical preparations and methods 5 of correcting the cellular alteration of a mutant CFTR protein wherein the CFTR mutation is a mutation AF508-CFTR, or another mutation of class II.

Drugs covered by this patent

Patent Metadata

Patent number
AU2015201409B2
Jurisdiction
AU
Classification
—
Expires
2016-11-03
Drug substance claim
No
Drug product claim
No
Assignee
Instytut Biochemii I Biofizyki of PAN
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.